Total Payments
$10,077
2024 Payments
$3,165
Companies
45
Transactions
428
Medicare Patients
2,321
Medicare Billing
$121,794
Payment Breakdown by Category
Food & Beverage$9,902 (98.3%)
Education$174.98 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,902 | 426 | 98.3% |
| Education | $174.98 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,941 | 101 | $0 (2024) |
| Novo Nordisk Inc | $1,093 | 46 | $0 (2024) |
| Lilly USA, LLC | $732.10 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $601.71 | 8 | $0 (2022) |
| Amgen Inc. | $554.06 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $406.24 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $368.17 | 11 | $0 (2024) |
| Gilead Sciences, Inc. | $362.85 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $333.52 | 17 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $261.32 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,165 | 115 | ABBVIE INC. ($498.17) |
| 2023 | $2,764 | 127 | ABBVIE INC. ($646.04) |
| 2022 | $1,622 | 66 | AstraZeneca Pharmaceuticals LP ($393.80) |
| 2021 | $2,526 | 120 | AbbVie Inc. ($525.83) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Biological | ||||||
| 12/05/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $121.62 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $99.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.72 | General |
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.27 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: HCV | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 573 | 686 | $108,936 | $24,815 |
| 2022 | 13 | 462 | 544 | $89,064 | $22,679 |
| 2021 | 19 | 702 | 945 | $121,309 | $43,626 |
| 2020 | 14 | 584 | 727 | $93,011 | $30,673 |
Total Patients
2,321
Total Services
2,902
Medicare Billing
$121,794
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 221 | $39,780 | $8,611 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 103 | $13,905 | $3,806 | 27.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $6,300 | $3,102 | 49.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $3,630 | $2,364 | 65.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 97 | 97 | $26,675 | $1,498 | 5.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 26 | $2,080 | $951.49 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,254 | $943.80 | 75.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 14 | $6,510 | $782.93 | 12.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $3,420 | $686.60 | 20.1% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 15 | 15 | $1,350 | $571.80 | 42.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $608.00 | $429.00 | 70.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 12 | $1,320 | $415.44 | 31.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 23 | $529.00 | $218.96 | 41.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $1,025 | $187.69 | 18.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 21 | 22 | $264.00 | $134.42 | 50.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 21 | 22 | $286.00 | $111.76 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 203 | $35,686 | $7,859 | 22.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $9,317 | $5,025 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 91 | $11,613 | $3,496 | 30.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 18 | 19 | $2,090 | $1,276 | 61.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $19,264 | $1,249 | 6.5% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 26 | 27 | $2,430 | $972.19 | 40.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $836.00 | $596.29 | 71.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 16 | $1,192 | $579.42 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 21 | $798.00 | $570.69 | 71.5% |
About Dorothy Baker, RN MSN ARNP
Dorothy Baker, RN MSN ARNP is a Registered Nurse healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568403616.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dorothy Baker, RN MSN ARNP has received a total of $10,077 in payments from pharmaceutical and medical device companies, with $3,165 received in 2024. These payments were reported across 428 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($9,902).
As a Medicare-enrolled provider, Baker has provided services to 2,321 Medicare beneficiaries, totaling 2,902 services with total Medicare billing of $121,794. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Registered Nurse, Family
- Location Florence, KY
- Active Since 06/09/2006
- Last Updated 09/07/2018
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1568403616
Products in Payments
- VRAYLAR (Drug) $1,009
- UBRELVY (Drug) $446.75
- MOUNJARO (Drug) $386.33
- Kerendia (Drug) $368.17
- JARDIANCE (Drug) $364.04
- NURTEC ODT (Drug) $341.91
- Wegovy (Drug) $331.37
- FARXIGA (Drug) $325.41
- Rybelsus (Drug) $316.99
- Otezla (Drug) $282.38
- REXULTI (Drug) $246.20
- Ozempic (Drug) $210.95
- Aimovig (Biological) $209.71
- TRELEGY ELLIPTA (Drug) $187.08
- INJECTAFER (Drug) $180.00
- Auvelity (Drug) $172.75
- ENTRESTO (Drug) $170.61
- QULIPTA (Drug) $169.97
- Saxenda (Drug) $164.31
- XIFAXAN (Drug) $160.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Florence
Joshua Blancher, Aprn, APRN
Registered Nurse — Payments: $9,247
Registered Nurse $9,247
Lillian Sudduth, Crnp, CRNP
Registered Nurse — Payments: $3,576
Registered Nurse $3,576
Tanya Thornton, Rn, RN
Registered Nurse — Payments: $636.39
Registered Nurse $636.39
Mary Vahle, Np, NP
Registered Nurse — Payments: $521.41
Registered Nurse $521.41
Mrs. Katlyn Mccabe, Crna, CRNA
Registered Nurse — Payments: $399.94
Registered Nurse $399.94
Mrs. Brittany Green, Crnp, CRNP
Registered Nurse — Payments: $218.38
Registered Nurse $218.38